Hae Lim Lee

911 total citations
34 papers, 566 citations indexed

About

Hae Lim Lee is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Hae Lim Lee has authored 34 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hepatology, 22 papers in Epidemiology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Hae Lim Lee's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers) and Hepatitis B Virus Studies (15 papers). Hae Lim Lee is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers) and Hepatitis B Virus Studies (15 papers). Hae Lim Lee collaborates with scholars based in South Korea, United States and Philippines. Hae Lim Lee's co-authors include Sung Won Lee, Seung Kew Yoon, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jung Hyun Kwon, Sun Hong Yoo, Nam Ik Han, Soon Woo Nam and Pil Soo Sung and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gut.

In The Last Decade

Hae Lim Lee

31 papers receiving 562 citations

Peers

Hae Lim Lee
Yasuhide Motoyoshi Japan
Nam Ik Han South Korea
Sawako Uchida‐Kobayashi Japan
Akeel Alisa United Kingdom
Edward Mena United States
Satoshi Shakado Japan
Jong Ryul Eun South Korea
Filippo Pelizzaro Italy
Fujimasa Tada Japan
Mengfei Liu United States
Yasuhide Motoyoshi Japan
Hae Lim Lee
Citations per year, relative to Hae Lim Lee Hae Lim Lee (= 1×) peers Yasuhide Motoyoshi

Countries citing papers authored by Hae Lim Lee

Since Specialization
Citations

This map shows the geographic impact of Hae Lim Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hae Lim Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hae Lim Lee more than expected).

Fields of papers citing papers by Hae Lim Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hae Lim Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hae Lim Lee. The network helps show where Hae Lim Lee may publish in the future.

Co-authorship network of co-authors of Hae Lim Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Hae Lim Lee. A scholar is included among the top collaborators of Hae Lim Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hae Lim Lee. Hae Lim Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Hae Lim, Soon Kyu Lee, Ji Won Han, et al.. (2025). Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B. JHEP Reports. 7(7). 101391–101391. 3 indexed citations
2.
Song, Do Seon, Jin Mo Yang, Young Kul Jung, et al.. (2024). Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial. Annals of Hepatology. 30(1). 101749–101749.
3.
Nam, Heechul, Ji Won Han, Soon Kyu Lee, et al.. (2024). Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B. Journal of Gastroenterology and Hepatology. 39(8). 1673–1683. 1 indexed citations
4.
Yang, Keungmo, Hyun Yang, Chang Wook Kim, et al.. (2024). Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct Invasion. Gut and Liver. 18(5). 877–887. 1 indexed citations
5.
Lee, Hae Lim, Seok‐Hwan Kim, Hee Yeon Kim, Sung Won Lee, & Myeong Jun Song. (2024). A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Frontiers in Oncology. 14. 1354964–1354964. 3 indexed citations
6.
7.
Lee, Han Ah, Hae Lim Lee, Jeong Eun Song, et al.. (2023). The efficacy of treatment for hepatocellular carcinoma in elderly patients. SHILAP Revista de lepidopterología. 23(2). 362–376. 4 indexed citations
8.
Nam, Heechul, Jaejun Lee, Ji Won Han, et al.. (2023). Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study. Liver Cancer. 13(4). 413–425. 7 indexed citations
9.
Yang, Hyun, Si Hyun Bae, Heechul Nam, et al.. (2022). A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance. Journal of Hepatology. 77(3). 632–641. 28 indexed citations
10.
Lee, Hae Lim, Si Hyun Bae, Jaejun Lee, et al.. (2021). Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus. Cancer Control. 28. 2895457806–2895457806. 1 indexed citations
11.
Lee, Hae Lim & Sung Won Lee. (2021). The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls. Clinical and Molecular Hepatology. 28(2). 121–134. 20 indexed citations
12.
Lee, Sung Won, Sung Min Kim, Wonhee Hur, et al.. (2021). Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway. PLoS ONE. 16(12). e0261067–e0261067. 27 indexed citations
13.
Song, Do Seon, Jin Mo Yang, Young Kul Jung, et al.. (2020). PE-013 : Rifaximin Treatment in Patients with Severe Alcoholic Hepatitis; A Multicenter, Open-Label, Pilot Randomized Controlled Trial. 2020(1). 172–172. 1 indexed citations
14.
Sung, Pil Soo, Jeong Won Jang, Jaejun Lee, et al.. (2020). Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection. Frontiers in Oncology. 10. 1043–1043. 27 indexed citations
15.
Lee, Hae Lim, Jung‐Min Lee, Sung‐Woo Cho, et al.. (2020). Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells. The Korean Journal of Internal Medicine. 37(1). 53–62. 10 indexed citations
16.
17.
Lee, Hae Lim, Jeong Won Jang, Sung Won Lee, et al.. (2019). Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization. Scientific Reports. 9(1). 3260–3260. 138 indexed citations
18.
Lee, Hae Lim, Jeong Won Jang, Ji Won Han, et al.. (2019). Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B. Digestive Diseases and Sciences. 64(10). 2992–3000. 6 indexed citations
19.
Yang, Hyun, Hyun Young Woo, Soon Kyu Lee, et al.. (2017). A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function. Clinical and Molecular Hepatology. 23(2). 128–137. 28 indexed citations
20.
Yang, Hyun, Pil Soo Sung, Jung Suk Oh, et al.. (2017). Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study. Journal of Vascular and Interventional Radiology. 28(11). 1503–1511.e2. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuhide Motoyoshi Breakdown of academic impact, for papers by Nam Ik Han Breakdown of academic impact, for papers by Sawako Uchida‐Kobayashi Breakdown of academic impact, for papers by Akeel Alisa Breakdown of academic impact, for papers by Edward Mena Breakdown of academic impact, for papers by Satoshi Shakado Breakdown of academic impact, for papers by Jong Ryul Eun Breakdown of academic impact, for papers by Filippo Pelizzaro Breakdown of academic impact, for papers by Fujimasa Tada Breakdown of academic impact, for papers by Mengfei Liu
Rankless by CCL
2026